At a glance
- Originator Pfizer
- Class Indoles; Neuroprotectants
- Mechanism of Action Serotonin 5-HT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 06 Dec 1995 No-Development-Reported for Neurological disorders in USA (Unknown route)